MGA012
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MGA012, covering 2021-11-10 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer [Phase 1]